SIREN : 828622241
NORD PHARMA HOLDING is a French company founded 9 years ago, specialized in the sector Gestion de fonds. Based in BERSEE (59235), this company of category PME shows in 2025 a net income positive of 130 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-25
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2025 | 2024 | 2023 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C | N/C |
| Net income | 130 058 € | 323 484 € | 147 783 € | 63 614 € | 95 443 € |
| EBITDA | -2 318 € | -8 131 € | -4 419 € | -2 536 € | -2 523 € |
| Net margin | N/C | N/C | N/C | N/C | N/C |
In 2025, NORD PHARMA HOLDING generates positive net income of 130 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2025: 95 k€ -> 130 k€.
-2 318 €
-2 318 €
130 058 €
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 98%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
0.019%
98.111%
-0.014
In 2025, the debt ratio of NORD PHARMA HOLDING (0.02) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2025, the financial autonomy of NORD PHARMA HOLDING (98.1%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2025, the repayment capacity of NORD PHARMA HOLDING (-0.01) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 2292.16. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
2292.159
0.0
In 2025, the liquidity ratio of NORD PHARMA HOLDING (2292.16) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2025, the interest coverage of NORD PHARMA HOLDING (0.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 559 days. Excellent situation: suppliers finance 559 days of the operating cycle (retail model).
0 €
0 j
559 j
0 j
Indicative estimate only : the number of comparable transactions in this sector is limited (40 transactions). This range of 168 860€ to 973 146€ is provided for information purposes only and requires in-depth analysis to be confirmed.
This estimate is based on the analysis of 40 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare NORD PHARMA HOLDING with other companies in the same sector:
The revenue of NORD PHARMA HOLDING is not publicly disclosed (confidential accounts filed with INPI).
Yes, NORD PHARMA HOLDING generated a net profit of 130 k€ in 2025.
The headquarters of NORD PHARMA HOLDING is located in BERSEE (59235), in the department Nord.
The tax return of NORD PHARMA HOLDING is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
NORD PHARMA HOLDING operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.